Effective 1 de enero de 2022, laparoscopic or transcervical radiofrequency ablation as a treatment of symptomatic uterine fibroids (CPT code 58674) will be considered medically necessary when the criteria in the BCBSRI medical policy has been met. This change is applicable for Medicare Advantage plans and commercial products. Additional information pertaining to the medical policy can be found here.